We are live on ! Find out more
ZJYL icon

Jin Medical International

2 hedge funds and large institutions have $42 invested in Jin Medical International in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% less ownership

Funds ownership: 0.25% → 0% (-0.25%)

50% less funds holding

Funds holding: 4 → 2 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less capital inflows, than outflows

Capital inflows: $47 | Capital outflows: $35.4K

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ZJYL Hedge Fund Activity: Q3 2026 in Review

2 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q3 2026, worth a combined $42 — down 100% from $35.4K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ZJYL and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Caitong International Asset Management, adding an estimated $31. The largest seller was HRT Financial, exiting entirely with an estimated $28K sold.

  • 2 institutional investors held Jin Medical International (ZJYL) as of Q3 2026, down from 4 in Q2 2026.
  • Funds reported $42 of Jin Medical International stock for Q3 2026, down 100% quarter-over-quarter.
  • 1 fund opened new Jin Medical International positions in Q3 2026 and 3 closed out, a net change of -2 holders.
  • The largest Jin Medical International buyer in Q3 2026 was Caitong International Asset Management, an estimated $31 added.
  • The largest Jin Medical International seller in Q3 2026 was HRT Financial, an estimated $28K sold.

Based on aggregated 13F filings for Q3 2026.